Abstract PS3-12-30: Targeting dendritic cells with CD40 agonist-based triplet immunotherapy induces IL12B-driven tumor control in triple-negative breast cancers
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Authors: P. L. Mylabathula, R. Ali, A. Alkhani, X. Qi, S. Hebbale, J. Zhu, I. Chan, S. M. Reddy
Institution: The University of Texas Southwestern Medical Center
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7129607481
Cites:
Cited by:
Related to:
